# 2025年11月11日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 亚重症监护室的绩效评估是否恰当？

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41214796](https://pubmed.ncbi.nlm.nih.gov/41214796)
**期刊：** Critical care (London, England)
**PMID：** 41214796
**DOI：** 10.1186/s13054-025-05676-1

### 第一部分 原文与翻译

**英文原标题：** Intermediate Care Unit performance being properly assessed?

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

本文献的标题以设问形式，直接点明了其核心议题：当前对亚重症监护室（Intermediate Care Unit, IMC）绩效的评估方法是否恰当。由于缺乏摘要，无法得知其具体的研究方法和数据支持，但可推断该文很可能是一篇评论或观点性文章。该文旨在探讨并反思现有IMC绩效评估体系的充分性与合理性，可能指出了当前评估标准中存在的缺陷或局限。此议题具有重要的临床管理价值，因为科学的绩效评估是优化医疗资源配置、提升护理质量及改善患者预后的关键，该文可能为建立更全面的评估框架提供了方向。

---

## 2. 探寻损伤肺的最佳机械通气策略：呼气时长的作用

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41214725](https://pubmed.ncbi.nlm.nih.gov/41214725)
**期刊：** Critical care (London, England)
**PMID：** 41214725
**DOI：** 10.1186/s13054-025-05683-2

### 第一部分 原文与翻译

**英文原标题：** Toward optimal mechanical ventilation of the injured lung: the role of expiratory duration.

**英文摘要原文：**
Positive pressure mechanical ventilation is a life-saving intervention for patients with acute respiratory distress syndrome (ARDS), but it can also increase mortality by causing ventilator-induced lung injury (VILI) if applied inappropriately. Although strategies like low-tidal volume ventilation and prone positioning have been shown to reduce mortality, the optimal patient-specific approach to mechanical ventilation in ARDS has yet to be identified. The worst manifestations of acute lung injury arise when fluid and proteins from the blood leak through a damaged blood-gas barrier, accumulating in the airspaces and impairing the ability of pulmonary surfactant to lower surface tension. This amplifies the ventilatory stresses in the lung tissues, which further damages the blood-gas barrier, leading to a vicious cycle of worsening injury. Studies suggest that VILI may be most effectively avoided by preventing the atelectrauma caused during inspiration by the forced reopening of lung units that close during each expiration. Atelectrauma is conventionally mitigated with positive end-expiratory pressure (PEEP), but it remains unclear if the algorithmic selection of PEEP leads to mortality reductions in ARDS. Animal studies, however, support the efficacy of exploiting the time-dependent nature of recruitment and derecruitment, for example through the use of brief expiratory durations that continually adapt to changing lung mechanics. Despite decades of research, it remains unclear how to minimize VILI in any given ARDS patient. Animal studies coupled with energy dissipation analysis indicate that the prevention of VILI requires, above all, avoidance of the atelectrauma caused by cyclic recruitment and derecruitment in the lung. In addition, the path to optimal mechanical ventilation in ARDS must be based not only on the amplitudes of the pressures applied to the lung but also on their temporal natures.

**中文摘要译文：**
对于急性呼吸窘迫综合征（ARDS）患者而言，正压机械通气是一种挽救生命的干预措施，但若应用不当，也可能因导致呼吸机相关性肺损伤（VILI）而增加死亡率。尽管低潮气量通气和俯卧位通气等策略已被证明可以降低死亡率，但针对ARDS患者的最佳个体化机械通气方法仍有待确定。当血液中的液体和蛋白质通过受损的血气屏障渗漏，积聚在肺泡腔内，并损害肺表面活性物质降低表面张力的能力时，便会出现急性肺损伤的最严重表现。这会加剧肺组织所受的通气应力，从而进一步损害血气屏障，导致损伤不断恶化的恶性循环。研究表明，要最有效地避免VILI，或许在于防止因每次呼气时闭合的肺单位在吸气时被强制重新开放而引起的肺不张性损伤（atelectrauma）。传统上，肺不张性损伤通过使用呼气末正压（PEEP）来减轻，但通过算法选择PEEP是否能降低ARDS的死亡率仍不清楚。然而，动物研究支持利用肺复张和去复张的时间依赖性特征的有效性，例如通过使用能持续适应肺力学变化的短暂呼气时长。尽管进行了数十年的研究，如何在任何给定的ARDS患者中最大程度地减少VILI仍不明确。动物研究结合能量耗散分析表明，预防VILI首先需要避免肺内周期性的复张和去复张所导致的肺不张性损伤。此外，实现ARDS最佳机械通气的路径不仅必须基于施加于肺部压力的幅度，还必须考虑其时间特性。

### 第二部分 AI 大师评价

该综述深刻探讨了急性呼吸窘迫综合征（ARDS）中机械通气的核心挑战——如何最大限度减少呼吸机相关性肺损伤（VILI）。文章创新性地将焦点从传统的压力参数（如PEEP）转移到通气的时间维度，特别是呼气时长。作者基于肺不张性损伤的病理生理机制，提出利用肺单位塌陷和复张的时间依赖性，通过动态调整并缩短呼气时间，可能是防止肺损伤的关键策略。该文为优化个体化通气方案提供了极具启发性的新视角，对未来的临床实践和相关研究具有重要的指导意义。

---

## 3. 独特的自身反应性CD19+浆细胞亚群在狼疮易感小鼠中积聚

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41213970](https://pubmed.ncbi.nlm.nih.gov/41213970)
**期刊：** Nature communications
**PMID：** 41213970
**DOI：** 10.1038/s41467-025-65906-6

### 第一部分 原文与翻译

**英文原标题：** Distinct autoreactive CD19 plasma cell subsets accumulate in lupus-prone mice.

**英文摘要原文：**
Plasma cells (PC) participate in the pathogenesis of systemic lupus erythematosus (SLE) through sustained autoantibody and inflammatory cytokine secretion. Current PC-depleting therapies risk eliminating protective long-lived PCs, highlighting the need to identify pathogenic subsets for selective targeting. Here, using single-cell RNA sequencing, B cell receptor repertoire analysis, and genetic models, we identify disease- and organ-specific PCs in lupus-prone mice. We find a substantial expansion of autoreactive CD19 PCs, particularly class-switched CXCR3⁺ and phosphatidylcholine-specific B-1-derived subsets, which exhibit unique gene expression profiles. We show that CD19 PCs originate from CD19 PCs in a unidirectional manner. Peripheral blood from SLE patients shows elevated frequencies of CD19 PCs, implicating these cells in sustaining pathogenic activity. Our findings highlight the emergence of autoreactive CD19 PCs as a critical feature of lupus pathogenesis in mice and underscore the need for therapeutic approaches that extend beyond CD19-targeting to improve treatment strategies in SLE.

**中文摘要译文：**
浆细胞（PC）通过持续分泌自身抗体和炎性细胞因子参与系统性红斑狼疮（SLE）的发病机制。目前的浆细胞清除疗法存在清除保护性长寿命浆细胞的风险，这凸显了识别致病性亚群以进行选择性靶向的必要性。本研究中，我们利用单细胞RNA测序、B细胞受体库分析和遗传模型，在狼疮易感小鼠中识别了疾病及器官特异性的浆细胞。我们发现自身反应性CD19+浆细胞显著扩增，特别是类别转换的CXCR3⁺亚群和磷脂酰胆碱特异性的B-1细胞衍生亚群，它们表现出独特的基因表达谱。我们证明了CD19+浆细胞单向来源于CD19-浆细胞。SLE患者的外周血显示CD19+浆细胞频率升高，这表明这些细胞参与维持致病活性。我们的研究结果凸显了自身反应性CD19+浆细胞的出现是小鼠狼疮发病机制的一个关键特征，并强调了需要开发超越CD19靶向的治疗方法以改进SLE的治疗策略。

### 第二部分 AI 大师评价

本研究旨在深入探究系统性红斑狼疮（SLE）中致病性浆细胞的异质性。研究团队综合运用单细胞测序、B细胞受体库分析等前沿技术，在狼疮小鼠模型中成功鉴定出独特的自身反应性CD19+浆细胞亚群，并揭示了其独特的基因表达谱及源自CD19-前体的分化路径。该研究不仅精准描绘了狼疮中关键致病细胞的特征，还发现其在SLE患者外周血中同样富集，这对于理解狼疮发病机制及指导开发超越传统CD19靶点的新型精准治疗策略具有重要的临床转化价值。

---

## 4. 肠道启动的中性粒细胞通过激活库普弗细胞促进小鼠脓毒症中的肝损伤

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41213940](https://pubmed.ncbi.nlm.nih.gov/41213940)
**期刊：** Nature communications
**PMID：** 41213940
**DOI：** 10.1038/s41467-025-65572-8

### 第一部分 原文与翻译

**英文原标题：** Gut-primed neutrophils activate Kupffer cells to promote hepatic injury in mouse sepsis.

**英文摘要原文：**
Sepsis-induced liver injury is common, but the underlying mechanisms remain poorly understood. Given the critical role of gut-liver crosstalk in sepsis, we hypothesize that gut-trained neutrophils, migrating via the portal vein, release neutrophil extracellular traps (NETs) to activate Kupffer cells, thereby exacerbating hepatic injury during sepsis. Here we show that iNOS expression in Kupffer cells increases in septic wild type mice but decreases in PAD4 mice. In vitro, NETs stimulate Kupffer cell IL-6 and TNF release, while conditioned media from NET-treated Kupffer cells induces hepatocyte death. Inhibition of neutrophil elastase and protease-activated receptor-1 (PAR-1) mitigates IL-6 and TNF secretion by Kupffer cells. Ex vivo, portal vein neutrophils from septic mice produce more NETs and induce greater Kupffer cell activation than systemic neutrophils, with this effect attenuated in PAD4 neutrophils. Furthermore, gut intraepithelial lymphocytes (IELs) interact with neutrophils during sepsis and facilitate NETosis, and IEL-primed neutrophils also induce Kupffer cell activation in vitro and in vivo. Our data thus suggest that IEL-facilitated, gut-derived neutrophil NETs activate Kupffer cells to contribute to sepsis-induced liver injury.

**中文摘要译文：**
脓毒症诱导的肝损伤很常见，但其潜在机制仍知之甚少。鉴于肠-肝串扰在脓毒症中的关键作用，我们假设经肠道训练的中性粒细胞通过门静脉迁移，释放中性粒细胞胞外诱捕网（NETs）来激活库普弗细胞，从而加剧脓毒症期间的肝损伤。本研究显示，在脓毒症野生型小鼠中，库普弗细胞的iNOS表达增加，但在PAD4小鼠中则减少。在体外实验中，NETs刺激库普弗细胞释放IL-6和TNF，而经NETs处理的库普弗细胞的条件培养基可诱导肝细胞死亡。抑制中性粒细胞弹性蛋白酶和蛋白酶激活受体-1（PAR-1）可减轻库普弗细胞分泌IL-6和TNF。在离体实验中，来自脓毒症小鼠门静脉的中性粒细胞比体循环中的中性粒细胞产生更多的NETs，并诱导更强的库普弗细胞活化，而这种效应在PAD4中性粒细胞中减弱。此外，在脓毒症期间，肠道上皮内淋巴细胞（IELs）与中性粒细胞相互作用并促进NETosis过程，而经IELs启动的中性粒细胞在体内和体外也能诱导库普弗细胞活化。因此，我们的数据表明，由IELs促进的、源自肠道的中性粒细胞NETs通过激活库普弗细胞，参与了脓毒症诱导的肝损伤过程。

### 第二部分 AI 大师评价

本研究旨在揭示脓毒症所致肝损伤的具体机制，聚焦于肠道启动的中性粒细胞在其中的作用。研究结合野生型及PAD4基因敲除小鼠模型、体外细胞共培养及离体细胞功能分析，关键性地发现肠道上皮内淋巴细胞（IELs）能够“启动”中性粒细胞，使其在迁移至肝脏后释放中性粒细胞胞外诱捕网（NETs），进而激活库普弗细胞，最终导致肝细胞损伤。该研究的创新之处在于详细阐明了“肠-IEL-中性粒细胞-库普弗细胞”这一全新的致病轴，强调了门静脉循环在传递损伤信号中的关键角色，为治疗脓毒症相关肝损伤提供了潜在的新靶点。

---

## 5. 印度蛇咬伤中毒的发病率、死亡率及社会经济负担的横断面调查

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41213936](https://pubmed.ncbi.nlm.nih.gov/41213936)
**期刊：** Nature communications
**PMID：** 41213936
**DOI：** 10.1038/s41467-025-64849-2

### 第一部分 原文与翻译

**英文原标题：** Cross-sectional survey of the incidence, mortality and socioeconomic burden of snakebite envenoming in India.

**英文摘要原文：**
Snakebite, a neglected tropical disease is a major cause of mortality and morbidity in India, despite which reliable nationwide data are limited. To address this, we carried out a survey in 25 districts across 11 states, covering a 60 million population. The community-based study was led by frontline health workers who tracked cases and deaths, while field teams collected details on the bite, the type of snake, treatment received, and costs. Data were gathered continuously for a one-year period. Here we show that 7,094 snakebite cases were recorded, with a mortality rate of 0.33 per 100,000 population. Nearly half of the reported deaths occurred outside hospital settings. Bites were most common in males (64.1%), adults aged 30-39 years (20.9%), and during the monsoon season (62.1%). Most victims (86.4%) sought hospital care, 60.2% received anti-snake venom, and 17.2% experienced side effects to the anti-venom. Treatment placed a heavy financial burden on families; average out-of-pocket expenditure was INR 6,500, with higher costs in private hospitals (INR 27,400) compared to public facilities (INR 3,900). And 47.5% of the victims belonged to households below the poverty line. These findings show that faster access to hospitals, improved anti-venoms, and health insurance are urgently needed to prevent avoidable deaths.

**中文摘要译文：**
蛇咬伤是一种被忽视的热带病，是印度死亡和发病的主要原因，然而尽管如此，可靠的全国性数据却很有限。为了解决这个问题，我们在11个邦的25个地区进行了一项调查，覆盖了6000万人口。这项基于社区的研究由一线卫生工作者主导，他们负责追踪病例和死亡情况，而现场团队则收集有关咬伤细节、蛇的类型、所接受的治疗以及相关费用的信息。数据在为期一年的时间内被持续收集。在此我们报告，共记录了7094例蛇咬伤病例，死亡率为每10万人口0.33例。近一半的报告死亡病例发生在医院外。咬伤最常见于男性（64.1%）、30-39岁的成年人（20.9%）以及季风季节（62.1%）。大多数受害者（86.4%）寻求了医院治疗，60.2%接受了抗蛇毒血清治疗，17.2%的患者出现了抗蛇毒血清的副作用。治疗给家庭带来了沉重的经济负担；平均自付费用为6500印度卢比，私立医院的费用（27400印度卢比）高于公立机构（3900印度卢比）。并且，47.5%的受害者来自贫困线以下的家庭。这些发现表明，为防止可避免的死亡，迫切需要提供更快捷的医院就诊途径、改良的抗蛇毒血清以及医疗保险。

### 第二部分 AI 大师评价

本研究通过在印度进行的一项大规模社区横断面调查，旨在填补该国关于蛇咬伤中毒发病率、死亡率和社会经济负担的全国性数据空白。研究的关键发现揭示了蛇咬伤在特定人群（男性、青壮年）和季节（季风季）的高发性，以及院外死亡率高和对贫困家庭造成巨大经济压力的严峻现实。这项研究的价值在于其提供了宝贵的一手流行病学证据，强有力地证明了改善医疗可及性、优化抗蛇毒血清和推广健康保险对于降低印度蛇咬伤所致可避免死亡的紧迫性和重要性。

---

## 6. 衰弱对院外心脏骤停后死亡率、功能结局和健康状况的影响：来自TTM2试验的见解

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41212202](https://pubmed.ncbi.nlm.nih.gov/41212202)
**期刊：** Intensive care medicine
**PMID：** 41212202
**DOI：** 10.1007/s00134-025-08185-5

### 第一部分 原文与翻译

**英文原标题：** Impact of frailty on mortality, functional outcome, and health status after out-of-hospital cardiac arrest: insights from the TTM2-trial.

**英文摘要原文：**
PURPOSE: To explore the association of frailty with mortality, functional outcome, and health status after out-of-hospital cardiac arrest.

METHODS: This is a cohort-based secondary analysis of the Targeted Hypothermia versus Targeted Normothermia after out-of-hospital cardiac arrest (TTM2) trial, an international, prospective, multicentre study. Frailty was assessed using the Clinical Frailty Scale (1-9): fit (1-3), prefrail (4), frail (5), and severely frail (6-9). Main outcomes were mortality and poor functional outcome (modified Rankin Scale 4-6) at 6 and 24 months. Additional outcomes included neuroprognostication, withdrawal-of-life-sustaining-therapies (WLST), functional decline (retrospectively reported pre-arrest versus 6 month Glasgow Outcome Scale Extended score), health status (EQ-5D-5L, EQ-VAS), and life satisfaction at 6 and 24 months.

RESULTS: Of 1861 participants, 240 (13%) were prefrail, and 188 (10%) were frail or severely frail. Mortality and poor functional outcome increased significantly with greater frailty. Compared to fit participants, adjusted ORs (95% CI) for 6 month mortality were: prefrail 2.7 (1.8-3.8), frail 3.7 (1.9-7.1), and severely frail 8.9 (4.2-18.7); and poor functional outcome: prefrail 2.9 (1.9-4.2), frail 3.9 (1.9-8.1), and severely frail 35.4 (8.4-148.8). Severely frail participants underwent neuroprognostication less often (p < 0.001), while WLST was more common in the prefrail, frail and severely frail (p < 0.001). Prefrail and frail survivors tended to report more frequent functional decline and lower health status, though with individual variation.

CONCLUSION: Frailty was associated with a significantly increased risk of mortality and poor functional outcome after out-of-hospital cardiac arrest. Findings suggest more frequent functional decline and lower overall health status in frail survivors.

TRIAL REGISTRATION: NCT02908308.

**中文摘要译文：**
目的：探讨院外心脏骤停后，衰弱与死亡率、功能结局及健康状况的关联。

方法：本研究是对“院外心脏骤停后目标性低体温与目标性正常体温对比”（TTM2）试验进行的一项基于队列的二次分析，该试验是一项国际性、前瞻性、多中心研究。衰弱状况采用临床衰弱量表（1-9分）进行评估，分为：健康（1-3分）、衰弱前期（4分）、衰弱（5分）和重度衰弱（6-9分）。主要结局为6个月和24个月时的死亡率和不良功能结局（改良Rankin量表评分为4-6分）。次要结局包括神经系统预后评估、撤除生命支持治疗（WLST）、功能下降（回顾性报告的心脏骤停前与6个月时格拉斯哥结局量表扩展版评分对比）、健康状况（EQ-5D-5L, EQ-VAS）以及6个月和24个月时的生活满意度。

结果：在1861名参与者中，240人（13%）为衰弱前期，188人（10%）为衰弱或重度衰弱。死亡率和不良功能结局随衰弱程度的加重而显著增加。与健康参与者相比，衰弱前期、衰弱和重度衰弱者6个月死亡率的校正比值比（95% CI）分别为：2.7（1.8-3.8）、3.7（1.9-7.1）和8.9（4.2-18.7）；不良功能结局的校正比值比则分别为：2.9（1.9-4.2）、3.9（1.9-8.1）和35.4（8.4-148.8）。重度衰弱的参与者接受神经系统预后评估的频率较低（p < 0.001），而撤除生命支持治疗在衰弱前期、衰弱和重度衰弱者中更为常见（p < 0.001）。衰弱前期和衰弱的幸存者倾向于报告更频繁的功能下降和更低的健康状况，尽管存在个体差异。

结论：衰弱与院外心脏骤停后死亡风险和不良功能结局风险的显著增加相关。研究结果提示，衰弱的幸存者中功能下降更频繁，总体健康状况更差。

试验注册号：NCT02908308。

### 第二部分 AI 大师评价

本研究基于高质量的TTM2临床试验数据，系统探究了衰弱对院外心脏骤停患者预后的影响。研究采用临床衰弱量表，明确揭示了衰弱程度与患者6个月及更长期的死亡率及不良功能结局风险呈显著正相关。该发现不仅为临床医生进行预后判断和治疗决策（如是否撤除生命支持）提供了关键依据，也强调了在心脏骤停复苏后管理中评估患者基线衰弱状况的重要性，具有重要的临床指导价值。

---

## 7. 心源性休克死亡率预测模型：一项系统评价与Meta分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41212048](https://pubmed.ncbi.nlm.nih.gov/41212048)
**期刊：** Critical care medicine
**PMID：** 41212048
**DOI：** 10.1097/CCM.0000000000006937

### 第一部分 原文与翻译

**英文原标题：** Predictive Models for Mortality in Cardiogenic Shock: A Systematic Review and Meta-Analysis.

**英文摘要原文：**
OBJECTIVES: Cardiogenic shock is a time-critical emergency requiring aggressive therapeutic interventions, yet prognostication remains challenging with no consensus on the comparative applicabilities of risk scores. Our study aims to evaluate the capacities of existing risk scores for efficient, effective, and generalizable prognostication of mortality across various patient demographic cohorts.

DATA SOURCES: We searched MEDLINE, Embase, and Scopus databases up to June 15, 2024.

STUDY SELECTION: We included articles developing, redeveloping, or validating a multivariable model predicting all-cause mortality in adults with cardiogenic shock.

DATA EXTRACTION: We pooled area under the curve (AUC) statistics and observed: expected (O:E) ratios as an assessment of discrimination and calibration, respectively. We conducted random-effects inverse-variance weighted meta-analyses on prespecified prediction models (Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock [IABP-SHOCK II], CardShock, Simplified Acute Physiology Score II, Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II, and Survival After Venoarterial Extracorporeal Membrane Oxygenation) to derive pooled estimates of AUCs and aggregate O:Es for each model. Subgroup analyses were conducted to identify sources of heterogeneity.

DATA SYNTHESIS: We included 102 studies comprising 126 study cohorts in our final analysis (89,546 patients), with 40 unique prediction models identified. There were no significant differences between the performances of all included scores. However, in terms of absolute pooled values, CardShock score had the highest pooled discrimination (AUC, 0.73 [95% CI, 0.70-0.76]) and best calibration (O:E, 1.06 [95% CI, 0.79-1.41]) among other widely used scores. Subgroup analyses were highly variable between studies and again did not reveal a superior prediction model. Unique prediction models developed by authors were found to be superior to existing prediction models, yet lacked generalizability.

CONCLUSIONS: Meta-analysis of six included scores revealed no clear "gold standard" prediction model, although the CardShock score had the highest discrimination and most accurate calibration. The degree of variability between studies precluded in-depth assessment of subgroup analysis. Further research into novel risk scores can be conducted to better inform clinicians on their utility.

**中文摘要译文：**
目的: 心源性休克是一种需要积极治疗干预的、时间紧迫的急症，然而其预后评估仍然充满挑战，且对于各种风险评分的比较适用性尚未达成共识。我们的研究旨在评估现有风险评分在不同患者人群中进行高效、有效且可推广的死亡率预后预测的能力。

数据来源: 我们检索了截至2024年6月15日的MEDLINE、Embase和Scopus数据库。

研究筛选: 我们纳入了开发、再开发或验证用于预测心源性休克成年患者全因死亡率的多变量模型的文章。

数据提取: 我们汇总了曲线下面积（AUC）统计数据和观察值与期望值（O:E）的比率，分别用于评估模型的区分度和校准度。我们对预设的预测模型（包括主动脉内球囊反搏在急性心肌梗死并发心源性休克中的应用II [IABP-SHOCK II]、CardShock、简化急性生理学评分II、序贯器官衰竭评估、急性生理学与慢性健康状况评估II，以及静脉-动脉体外膜肺氧合后生存评分）进行了随机效应反方差加权Meta分析，以得出每个模型的汇总AUC估计值和总体O:E比率。我们还进行了亚组分析以确定异质性的来源。

数据综合: 我们的最终分析纳入了102项研究，共计126个研究队列（89,546名患者），识别出40种独特的预测模型。所有纳入评分的表现之间没有显著差异。然而，从汇总的绝对值来看，在其他广泛使用的评分中，CardShock评分具有最高的汇总区分度（AUC, 0.73 [95% CI, 0.70-0.76]）和最佳的校准度（O:E, 1.06 [95% CI, 0.79-1.41]）。亚组分析在不同研究间差异很大，同样未能揭示出某个更优的预测模型。研究者自行开发的独特预测模型被发现优于现有预测模型，但缺乏普适性。

结论: 对六种纳入评分的Meta分析显示，目前尚无明确的“金标准”预测模型，尽管CardShock评分拥有最高的区分度和最准确的校准度。研究之间的高度变异性阻碍了对亚组分析的深入评估。未来可对新型风险评分进行进一步研究，以便更好地为临床医生提供其效用信息。

### 第二部分 AI 大师评价

本研究通过大规模系统评价与Meta分析，对心源性休克死亡率的多种预测模型进行了全面的性能评估。研究发现，尽管现有评分模型众多，但没有一个能作为“金标准”脱颖而出，其中CardShock评分在区分度和校准度上表现相对最佳。该研究的价值在于系统性地梳理了该领域的现状，指出了当前预后工具的局限性，并强调了开发更具普适性的新型风险评分模型对于指导临床决策的迫切需求。

---

## 8. 静脉-动脉体外膜肺氧合期间的神经系统并发症及其对6个月以患者为中心结局的影响

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41212045](https://pubmed.ncbi.nlm.nih.gov/41212045)
**期刊：** Critical care medicine
**PMID：** 41212045
**DOI：** 10.1097/CCM.0000000000006938

### 第一部分 原文与翻译

**英文原标题：** Neurological Complications During Venoarterial Extracorporeal Membrane Oxygenation and Their Implications for 6-Month Patient-Centered Outcomes.

**英文摘要原文：**
OBJECTIVES: Venoarterial extracorporeal membrane oxygenation (ECMO) is associated with neurologic complications but their impact on long-term outcomes are poorly understood. Our objective was to assess the association of neurologic complications with death and new disability at 6 months.

DESIGN: Prospective, multicenter, observational study.

SETTING: Thirty ECMO centers in Australia and New Zealand between February 2019 and December 2022.

SUBJECTS: seven hundred four adult patients admitted to the ICU on venoarterial ECMO other than for extracorporeal cardiopulmonary resuscitation.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: Patients were divided according to whether they experienced neurologic complications. Neurologic complications include diffuse cerebral ischemia, stroke, cerebral hemorrhage, and brain death. The primary outcome was a composite of death or new disability at 6 months. Secondary outcomes included disability measured by the World Health Organization Disability Assessment Schedule and quality of life measured with EuroQoL 5D five levels. The median age of patients was 54.5 years (42-64 yr) and 259 (36.8%) were female. The primary outcome was available for 613 of 706 patients (86.2%). Of these, 425 patients (69.3%) had either died or had new disability at 6 months. Neurologic events occurred in 85 patients (12%). Patients who experienced neurologic complications were at increased risk of death or new disability (risk difference [RD], 17.28% [6.44-25.92%]). This was primarily due to an increased risk of mortality RD, 23.75 (12.06-34.75) rather than new disability (RD, -11.90% [-30.58% to 13.56%]). These findings were consistent across types of complications and after adjustment for confounders. Patients with neurologic complications more commonly had ECMO discontinued due to a perceived poor prognosis (odds ratio, 2.7; 95% CI, 1.35-24.7).

CONCLUSIONS: Neurologic complications during ECMO increased the risk of death and disability at 6 months, primarily driven by increased death at 6 months. Prevention of these complications and development of better prognostic tools for functional outcomes should be prioritized.

**中文摘要译文：**
目的：静脉-动脉体外膜肺氧合（ECMO）与神经系统并发症相关，但其对长期结局的影响尚不明确。我们的目标是评估神经系统并发症与6个月时死亡和新发残疾的关联。

设计：前瞻性、多中心、观察性研究。

地点：2019年2月至2022年12月期间，位于澳大利亚和新西兰的30个ECMO中心。

受试者：704名因体外心肺复苏以外原因接受静脉-动脉ECMO治疗并入住ICU的成年患者。

干预措施：无。

测量与主要结果：根据患者是否出现神经系统并发症进行分组。神经系统并发症包括弥漫性脑缺血、卒中、脑出血和脑死亡。主要结局是6个月时的死亡或新发残疾的复合结局。次要结局包括使用世界卫生组织残疾评估量表（World Health Organization Disability Assessment Schedule）测量的残疾情况，以及使用欧洲五维五水平健康量表（EuroQoL 5D five levels）测量​​的生活质量。患者的中位年龄为54.5岁（42-64岁），其中259名（36.8%）为女性。706名患者中，有613名（86.2%）获得了主要结局数据。在这些患者中，425名（69.3%）在6个月时死亡或出现新发残疾。85名患者（12%）发生了神经系统事件。出现神经系统并发症的患者，其死亡或新发残疾的风险增加（风险差[RD], 17.28% [6.44-25.92%]）。这主要是由于死亡风险的增加（RD, 23.75 [12.06-34.75]），而非新发残疾风险的增加（RD, -11.90% [-30.58% to 13.56%]）。这些发现在不同类型的并发症中以及在对混杂因素进行调整后均保持一致。因预后不佳而中止ECMO治疗的情况，在发生神经系统并发症的患者中更为常见（比值比, 2.7; 95% CI, 1.35-24.7）。

结论：ECMO期间的神经系统并发症增加了6个月时死亡和残疾的风险，这主要是由6个月时死亡率的增加所驱动的。应优先预防这些并发症，并开发更好的功能性结局预后工具。

### 第二部分 AI 大师评价

本研究通过一项大规模前瞻性多中心观察性研究，精准探讨了VA-ECMO期间神经系统并发症对患者6个月结局的核心影响。其关键发现是，这类并发症显著增加了死亡或新发残疾的复合风险，且此风险主要由死亡率升高驱动，而非幸存者的残疾率增加。这项研究为ECMO重症监护领域的临床决策和预后判断提供了高质量的证据，其结论对于指导治疗目标、与患者家属沟通以及未来探索神经保护策略具有重要的临床价值。

---

速递结束，祝您工作愉快！